278 related articles for article (PubMed ID: 21074015)
1. Hormonal evaluation and midcycle detection of intrauterine glycodelin in women treated with levonorgestrel as in emergency contraception.
Durand M; Koistinen R; Chirinos M; Rodríguez JL; Zambrano E; Seppälä M; Larrea F
Contraception; 2010 Dec; 82(6):526-33. PubMed ID: 21074015
[TBL] [Abstract][Full Text] [Related]
2. Late follicular phase administration of levonorgestrel as an emergency contraceptive changes the secretory pattern of glycodelin in serum and endometrium during the luteal phase of the menstrual cycle.
Durand M; Seppala M; Cravioto Mdel C; Koistinen H; Koistinen R; González-Macedo J; Larrea F
Contraception; 2005 Jun; 71(6):451-7. PubMed ID: 15914136
[TBL] [Abstract][Full Text] [Related]
3. Effect of levonorgestrel-releasing intrauterine device on hormonal profile and menstrual pattern after long-term use.
Xiao B; Zeng T; Wu S; Sun H; Xiao N
Contraception; 1995 Jun; 51(6):359-65. PubMed ID: 7554977
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of ovulation by progestin analogs (agonists vs antagonists): preliminary evidence for different sites and mechanisms of actions.
Heikinheimo O; Gordon K; Williams RF; Hodgen GD
Contraception; 1996 Jan; 53(1):55-64. PubMed ID: 8631191
[TBL] [Abstract][Full Text] [Related]
5. A single midcycle dose of levonorgestrel similar to emergency contraceptive does not alter the expression of the L-selectin ligand or molecular markers of endometrial receptivity.
Palomino WA; Kohen P; Devoto L
Fertil Steril; 2010 Oct; 94(5):1589-94. PubMed ID: 19909947
[TBL] [Abstract][Full Text] [Related]
6. On the mechanisms of action of short-term levonorgestrel administration in emergency contraception.
Durand M; del Carmen Cravioto M; Raymond EG; Durán-Sánchez O; De la Luz Cruz-Hinojosa M; Castell-Rodríguez A; Schiavon R; Larrea F
Contraception; 2001 Oct; 64(4):227-34. PubMed ID: 11747872
[TBL] [Abstract][Full Text] [Related]
7. Effects of a sequential regimen of mifepristone-medroxyprogesterone acetate on ovarian function, endometrial development and hormonal parameters.
Croxatto HB; Massai MR; Salvatierra AM; Fuentealba B; Croxatto HD; Lähteenmäki P
Contraception; 1996 Aug; 54(2):79-86. PubMed ID: 8842583
[TBL] [Abstract][Full Text] [Related]
8. Levonorgestrel administration in emergency contraception: bleeding pattern and pituitary-ovarian function.
Tirelli A; Cagnacci A; Volpe A
Contraception; 2008 May; 77(5):328-32. PubMed ID: 18402847
[TBL] [Abstract][Full Text] [Related]
9. Sonographic assessment of ovarian and endometrial changes during long-term Norplant use and their correlation with hormonal levels.
Shaaban MM; Segal S; Salem HT; Ghaneimah SA; Khalifa EA; Ahmed AG
Fertil Steril; 1993 May; 59(5):998-1002. PubMed ID: 8486202
[TBL] [Abstract][Full Text] [Related]
10. Levonorgestrel-releasing intrauterine device-wearing women express contraceptive glycodelin A in endometrium during midcycle: another contraceptive mechanism?
Mandelin E; Koistinen H; Koistinen R; Affandi B; Seppälä M
Hum Reprod; 1997 Dec; 12(12):2671-5. PubMed ID: 9455833
[TBL] [Abstract][Full Text] [Related]
11. Effect of a single vaginal administration of levonorgestrel in Carraguard gel on the ovulatory process: a potential candidate for "dual protection" emergency contraception.
Brache V; Croxatto H; Sitruk-Ware R; Maguire R; Montero JC; Kumar N; Salvatierra AM; Tejada AS; Cochón L; Forcelledo ML; Lahteenmaki P; Alvarez F; Faundes A
Contraception; 2007 Aug; 76(2):111-6. PubMed ID: 17656180
[TBL] [Abstract][Full Text] [Related]
12. Effect of single administration of levonorgestrel on the menstrual cycle.
Okewole IA; Arowojolu AO; Odusoga OL; Oloyede OA; Adeleye OA; Salu J; Dada OA
Contraception; 2007 May; 75(5):372-7. PubMed ID: 17434019
[TBL] [Abstract][Full Text] [Related]
13. Ulipristal acetate prevents ovulation more effectively than levonorgestrel: analysis of pooled data from three randomized trials of emergency contraception regimens.
Brache V; Cochon L; Deniaud M; Croxatto HB
Contraception; 2013 Nov; 88(5):611-8. PubMed ID: 23809278
[TBL] [Abstract][Full Text] [Related]
14. The effects of peri-ovulatory administration of levonorgestrel on the menstrual cycle.
Hapangama D; Glasier AF; Baird DT
Contraception; 2001 Mar; 63(3):123-9. PubMed ID: 11368983
[TBL] [Abstract][Full Text] [Related]
15. Ultrasonographic and endocrine evaluation of ovarian function among Norplant implants users with regular menses.
Alvarez F; Brache V; Faundes A; Tejada AS; Thevenin F
Contraception; 1996 Nov; 54(5):275-9. PubMed ID: 8934060
[TBL] [Abstract][Full Text] [Related]
16. Onapristone (ZK 98.299): a potential antiprogestin for endometrial contraception.
Katkam RR; Gopalkrishnan K; Chwalisz K; Schillinger E; Puri CP
Am J Obstet Gynecol; 1995 Sep; 173(3 Pt 1):779-87. PubMed ID: 7573244
[TBL] [Abstract][Full Text] [Related]
17. Effect of low daily doses of mifepristone on ovarian function and endometrial development.
Danielsson KG; Swahn ML; Westlund P; Johannisson E; Seppälä M; Bygdeman M
Hum Reprod; 1997 Jan; 12(1):124-31. PubMed ID: 9043916
[TBL] [Abstract][Full Text] [Related]
18. Effect of two antiprogestins (mifepristone and onapristone) on endometrial factors of potential importance for implantation.
Cameron ST; Critchley HO; Buckley CH; Kelly RW; Baird DT
Fertil Steril; 1997 Jun; 67(6):1046-53. PubMed ID: 9176442
[TBL] [Abstract][Full Text] [Related]
19. Ovarian function after seven years' use of a levonorgestrel IUD.
Barbosa I; Olsson SE; Odlind V; Goncalves T; Coutinho E
Adv Contracept; 1995 Jun; 11(2):85-95. PubMed ID: 7491859
[TBL] [Abstract][Full Text] [Related]
20. Delayed endometrial maturation induced by daily administration of the antiprogestin RU 486: a potential new contraceptive strategy.
Batista MC; Cartledge TP; Zellmer AW; Merino MJ; Axiotis C; Loriaux DL; Nieman LK
Am J Obstet Gynecol; 1992 Jul; 167(1):60-5. PubMed ID: 1442957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
